ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "extracellular matrix proteins and osteoarthritis"

  • Abstract Number: 2123 • 2016 ACR/ARHP Annual Meeting

    Follistatin-like Protein 1 Is a Potent Regulator of Articular Chondrocytes in Osteoarthritis

    Yury Chaly, Bruce Hostager, Sonja Smith and Raphael Hirsch, Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA

    Background/Purpose: Osteoarthritis (OA) is the most common degenerative disease of the joints, affecting nearly 30 million Americans. It is characterized by a change in chondrocyte…
  • Abstract Number: 2951 • 2014 ACR/ARHP Annual Meeting

    Syndecan-4 Regulates Chondrocyte Phenotype and Cartilage Homeostasis Via the WNT Signaling Pathway

    Charlotte Kimberley Clarke1, Annelena Held1, Richard Stange2, Uwe Hansen3, Lars Godmann4, Jessica Bertrand5, Thomas Pap6, Giovanna Nalesso7, Frank Echtermeyer8, Francesco Dell'Accio9 and Joanna Sherwood7, 1University Hospital Muenster, Institute of Experimental Musculoskeletal Medicine (IEMM), Muenster, 48149, Germany, 2Dept. of Trauma, Hand and Reconstructive Surgery, University Hospital Münster, Münster, Germany, 3Institute for Physiological Chemistry & Pathobiochemistry, University Hospital Münster, Münster, Germany, 4Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany, 5Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany, 6Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 7Centre for Experimental Medicine and Rheumatology, Queen Mary University London, London, United Kingdom, 8Dept. of Anaesthesiology and Intensive Care Medicine, University Hospital Hannover, Hanover, Germany, 9William Harvey Research Institute, Barts and the London Queen Mary's School of Medicine and Dentistry, Centre for Experimental Medicine and Rheumatology, London, United Kingdom

    Background/Purpose Syndecan-4 (Sdc4), family member of type I transmembrane heparan sulfate proteoglycans (HSPGs), is a regulator of various cartilage-related processes including osteoarthritis (OA). Blockade of…
  • Abstract Number: 10 • 2012 ACR/ARHP Annual Meeting

    Fibronectin Fragment Induces Procatabolic Effects Through TLR-2 Signaling Pathway in Human Articular Chondrocytes

    Su Jin Park1, Eun-Jeong Cheon2 and Hyun Ah Kim3, 1Department of Internal Medicine, Hallym University Sacred Heart Hospital, Kyunggi, South Korea, 2Department of internal medicine, Hallym University Sacred Heart Hospital, Kyunggi, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Hallym university, Kyunggi, South Korea

    Background/Purpose: Fibronectin fragments (FN-fs) are increased in the synovial fluid of osteoarthritis patients and have a potent chondrolytic effect. However, little is known about the…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology